C07F 9/3882
Arylalkanephosphonic acids
Official title: {Arylalkanephosphonic acids (C07F9/3839 takes precedence)}
C07F9/3882 (Arylalkanephosphonic acids) appears on 169 US grants and 120 published applications in this corpus.
Search patents in C07F- Granted patents
- 169
- Published applications
- 120
- Assignees
- 114
- Inventors
- 486
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 3 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 6 | 0 |
| 1994 | 7 | 0 |
| 1995 | 8 | 0 |
| 1996 | 7 | 0 |
| 1997 | 5 | 0 |
| 1998 | 4 | 0 |
| 1999 | 6 | 0 |
| 2000 | 7 | 0 |
| 2001 | 3 | 0 |
| 2002 | 8 | 10 |
| 2003 | 4 | 3 |
| 2004 | 3 | 5 |
| 2005 | 2 | 9 |
| 2006 | 1 | 7 |
| 2007 | 5 | 8 |
| 2008 | 4 | 5 |
| 2009 | 5 | 13 |
| 2010 | 6 | 4 |
| 2011 | 2 | 6 |
| 2012 | 9 | 7 |
| 2013 | 7 | 6 |
| 2014 | 2 | 6 |
| 2015 | 3 | 6 |
| 2016 | 4 | 0 |
| 2017 | 3 | 5 |
| 2018 | 1 | 3 |
| 2019 | 3 | 2 |
| 2020 | 1 | 2 |
| 2021 | 3 | 3 |
| 2022 | 2 | 2 |
| 2023 | 0 | 2 |
| 2024 | 3 | 3 |
| 2025 | 0 | 2 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Small molecule degraders of STAT38 Sep 2026US 12,729,213 B2The Regents of the University of Michigan
- Ligands for nano-sized materials26 May 2026US 12,637,486 B2Samsung Electronics Co., Ltd.
- Electrochromic element17 Sep 2024US 12,091,612 B2Ricoh Company, Ltd.
- Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders25 Jun 2024US 12,016,856 B2Ardelyx, Inc.
- Phosphate derivatives and use thereof5 Mar 2024US 11,918,593 B2Shanghai Shengyue Pharmaceutical Technology Co., Ltd.
- Ptp1b/tc-ptp dual inhibitors and protein degraders20 Aug 2026US 2026/0240878 A1Purdue Research Foundation
- Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders4 Dec 2025US 2025/0367188 A1Ardelyx, Inc.
- Sulfonated and phosphorylated aromatic molecules27 Mar 2025US 2025/0100963 A1Xavier University of Louisiana
- Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders7 Nov 2024US 2024/0366590 A1Ardelyx, Inc.
- Organic compound and use thereof, passivation film, solar battery, and electrical apparatus12 Sep 2024US 2024/0301286 A1Contemporary Amperex Technology Co., Limited
Most cited
By later US patents
- Amino acid derivatives, the process for their preparation and their applications to therapy85US 5,599,951 ASociete Civile Bioprojet · 1997
- .alpha.-phosphonosulfonate squalene synthetase inhibitors77US 5,712,396 A1998
- Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives56US 4,452,790 AE. R. Squibb & Sons, Inc. · 1984
- Phosphorus containing compounds and use as hypotensives56US 4,555,506 AE. R. Squibb & Sons, Inc. · 1985
- Phenyl glycines for use in reducing neurotoxic injury56US 4,918,064 AG. D. Searle & Co. · 1990